![](/img/cover-not-exists.png)
Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 μg and ethinylestradiol 15 μg (Minesse®)
Ione C. Barbosa, Carlos Isaia Filho, Dirceu Faggion Jr., Edmund Chada BaracatVolume:
73
Year:
2006
Language:
english
Pages:
34
DOI:
10.1016/j.contraception.2005.06.057
File:
PDF, 117 KB
english, 2006